Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T15:46:23.715Z.
Calculation as of: 2026-10-06T15:46:23.715Z.
Quote observation: 2026-10-06T15:45:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e78bbdb3a8988fdd9fdd63a4dcf124b38851ed281a9b1f93071349952e7e00d5
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$43.99M
Free Cash Flow Yield
N/A
TTM Avg
8.38%
3Y Avg
7.29%
5Y Avg
5.95%
Market Cap
$45.21M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.92M
Free Cash Flow Yield
1.88%
TTM Avg
1.42%
3Y Avg
1.97%
5Y Avg
1.97%
Market Cap
$41.70M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$40.28M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CVRx, Inc. (CVRX) | $44.18M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.99M | N/A | 8.38% | 7.29% | 5.95% |
| Nano-X Imaging Ltd. (NNOX)vs › | $44.30M | N/A | N/A | N/A | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.21M | N/A | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.37M | N/A | N/A | N/A | N/A |
| Precipio, Inc. (PRPO)vs › | $41.92M | 1.88% | 1.42% | 1.97% | 1.97% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.70M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $40.06M | N/A | 4.03% | 3.27% | 3.27% |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.05M | N/A | 1.01% | 1.01% | 1.12% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
